| | Article status | Date reviewed |
|---|
| Blind Painful Eye | Up to Date | 14 September 2026 |
| Canaliculitis | Up to Date | 23 July 2026 |
| Conjunctival Papilloma | Up to Date | 14 September 2026 |
| Eccrine Sweat Gland Carcinoma | Up to Date | 19 October 2026 |
| Ectropion | Up to Date | 19 October 2026 |
| Erdheim-Chester Disease | Up to Date | 14 September 2026 |
| Exophthalmometry | Up to Date | 19 October 2026 |
| Eyelid Laceration | Up to Date | 14 September 2026 |
| Fibrous Dysplasia | Up to Date | 14 September 2026 |
| Frontocutaneous Fistula | Up to Date | 14 September 2026 |
| Giant Fornix Syndrome | Up to Date | 14 September 2026 |
| Intravascular Papillary Endothelial Hyperplasia | Up to Date | 14 September 2026 |
| Madarosis | Up to Date | 23 July 2026 |
| Mohs Micrographic Surgery | Up to Date | 14 September 2026 |
| Ocular Manifestations of Bosma Arrhinia Microphthalmia Syndrome (BAMS) | Up to Date | 14 September 2026 |
| Ocular Manifestations of Cutaneous T-Cell Lymphoma | Up to Date | 23 July 2026 |
| Optic Nerve Glioma | Up to Date | 14 September 2026 |
| Optical Lens Tinting and Wavelength-Specific Filters | Up to Date | 23 July 2026 |
| Orbital Roof fractures | Up to Date | 23 July 2026 |
| Photo-Oculodynia | Up to Date | 16 July 2026 |
| Pre-Ophthalmologist Management of Eye Trauma | Up to Date | 14 September 2026 |
| Sinonasal Undifferentiated Carcinoma | Up to Date | 23 July 2026 |
| Teprotumumab | Up to Date | 7 October 2026 |
